{"id":36542,"date":"2021-01-15T18:01:00","date_gmt":"2021-01-15T16:01:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&p=36542"},"modified":"2023-08-31T08:02:07","modified_gmt":"2023-08-31T06:02:07","slug":"toxins-2021-de-nouvelles-analyses-de-donnees-issues-detudes-pivotales-de-phase-iii-mettent-en-evidence-la-duree-daction-prolongee-de-dysport-abobotulinumtoxina-dans-cinq-in","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/toxins-2021-de-nouvelles-analyses-de-donnees-issues-detudes-pivotales-de-phase-iii-mettent-en-evidence-la-duree-daction-prolongee-de-dysport-abobotulinumtoxina-dans-cinq-in\/","title":{"rendered":"TOXINS 2021 : de nouvelles analyses de donn\u00e9es issues d\u2019\u00e9tudes pivotales de Phase III mettent en \u00e9vidence la dur\u00e9e d\u2019action prolong\u00e9e de Dysport\u00ae (abobotulinumtoxinA) dans cinq indications th\u00e9rapeutiques"},"content":{"rendered":"